Surgical Antibiotic Prophylaxis Utilization for Pediatric Thyroid Operations: A NSQIP-Pediatric Analysis
Erica C Arnold1, Yueran Zhang1, Kris R Jatana2
1Center for Surgical Outcomes Research, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, USA.
Journal of Pediatric Surgery
|July 24, 2026
Summary
Surgical antibiotic prophylaxis (SAP) is used in less than half of pediatric thyroid operations. While SSI risk is low, SAP may benefit patients with thyrotoxicosis or high BMI undergoing total thyroidectomy.
Area of Science:
- Pediatric Surgery
- Surgical Outcomes
- Infectious Disease
Background:
- Thyroid operations are generally clean procedures with no established pediatric-specific guidelines for surgical antibiotic prophylaxis (SAP).
- Understanding SAP utilization and its impact on surgical site infection (SSI) rates in children undergoing thyroid surgery is crucial.
Purpose of the Study:
- To assess the utilization of SAP in pediatric thyroid operations.
- To determine the association between SAP and SSI rates in pediatric patients.
Main Methods:
- Analysis of pediatric thyroid lobectomy and total thyroidectomy cases (2021-2023) from the NSQIP-P database.
- Exclusion of patients with pre-existing infections or non-clean wound classes.
- Comparison of SSI rates between patients who received SAP and those who did not.
Main Results:
- SAP was administered in 45.1% of 1,040 pediatric thyroid procedures.
- The overall SSI rate was low at 0.6%, with all SSIs occurring in the no-SAP group (1.1%).
- Patients with SSI often had total thyroidectomy, thyrotoxicosis, and BMI >85th percentile.
Conclusions:
- The risk of SSI after pediatric thyroid surgery is very low.
- Consider SAP for pediatric patients undergoing total thyroidectomy for thyrotoxicosis or with a BMI >85th percentile.
- Antibiotic stewardship is recommended for other pediatric thyroid surgery patients unlikely to benefit from SAP.
